Prognosis of prostate cancer by artificial neural networks

In this study, an artificial neural network has been devised that yields a prognostic result indicating whether patients have cancer or not using their free prostate-specific antigen, total prostate-specific antigen and age data. Though this system does not diagnose cancer conclusively, it helps the doctor in deciding whether a biopsy is necessary by providing information about whether the patient has prostate cancer or not. Data from 121 patients who were definitively diagnosed with cancer after biopsy were used in devising the system. The results of the definitive diagnoses of the patients and the results of the ANN that was performed were analysed using confusion matrix and ROC analyses. As a result of ANN, which was implemented on the basis of these analyses, success rates of 94.11% and 94.44% were achieved for prognosis of disease and validity, respectively. The ANN, which yielded these high rates of reliability, will help doctors make quick and reliable diagnoses without any risks and make it a better option to monitor patients with low prostate cancer risk on whom biopsies must not be carried out through a policy of wait and see.

[1]  B. Tombal,et al.  Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA. , 1996, Urology.

[2]  M K Brawer.  Prostate-specific antigen. , 2000, Seminars in surgical oncology.

[3]  Raouf N. Gorgui-Naguib,et al.  A fuzzy logic based-method for prognostic decision making in breast and prostate cancers , 2003, IEEE Transactions on Information Technology in Biomedicine.

[4]  Maysam F. Abbod,et al.  Survey of utilisation of fuzzy technology in Medicine and Healthcare , 2001, Fuzzy Sets Syst..

[5]  A. Ronco,et al.  Improving ultrasonographic diagnosis of prostate cancer with neural networks. , 1999, Ultrasound in medicine & biology.

[6]  Vladik Kreinovich,et al.  Fuzzy logic and its applications in medicine , 2001, Int. J. Medical Informatics.

[7]  T. Uchida,et al.  The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in japan , 1997, Cancer.

[8]  J Drago,et al.  The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men , 1991, Cancer.

[9]  Novruz Allahverdi,et al.  A fuzzy expert system design for diagnosis of prostate cancer , 2003, CompSysTech '03.

[10]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[11]  B. Tombal,et al.  Free to total prostate‐specific antigen (PSA) ratio is superior to total‐PSA in differentiating benign prostate hypertrophy from prostate cancer , 1996, The Prostate. Supplement.

[12]  H. Ermert,et al.  Comparison of different Neuro-Fuzzy classification systems for the detection of prostate cancer in ultrasonic images , 1997, 1997 IEEE Ultrasonics Symposium Proceedings. An International Symposium (Cat. No.97CH36118).

[13]  Jerome P. Richie,et al.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.

[14]  Thomas Tolxdorff,et al.  Classification Models for Early Detection of Prostate Cancer , 2008, Journal of biomedicine & biotechnology.

[15]  Yoichi Hayashi,et al.  Knowledge acquisition in the fuzzy knowledge representation framework of a medical consultation system , 2004, Artif. Intell. Medicine.

[16]  Mehmet Engin,et al.  Early prostate cancer diagnosis by using artificial neural networks and support vector machines , 2009, Expert Syst. Appl..